The analysts said GLP-1 sales could reach $102 billion by 2030, of which obesity is projected to contribute $41 billion. Two leaders in this field are expected to take roughly 44% and 52% share, respectively, of the global GLP-1 market in 2030. With high financial gain predicted, supply issues have been raised concerning how companies will meet the growing demand
Clean ingredients, no fillers finally something that delivers on the GLP-1 support promises
Modulatory potential of curcumin and resveratrol on P53 post-translational modifications during gastric cancer
In addition, irisin concentration was correlated with gender (Zgel et al., 2016)
Dubovskiy IM, Kryukova NA, Glupov VV, Ratcliffe NA (2016) Encapsulation and nodulation in insects
May also help with mood and cognitive function